Drug intelligence / Profile preview

euphorbia prostrata extract

Development stage
Phase 2
Lead developer
Panacea Biotec
Administration
Oral, Topical
01

Overview

**Euphorbia prostrata extract** is a standardized dry extract derived from the aerial parts of the plant *Euphorbia prostrata* (family Euphorbiaceae), approved in India since 2008 as a drug of modern medicine for hemorrhoidal disease. Rich in flavonoids (e.g., apigenin, luteolin, quercetin-3-O-glucoside, kaempferol-3-O-rutinoside), phenolic acids (e.g., gallic acid, ellagic acid, caffeic acid), tannins, and terpenoids (e.g., β-amyrin, taraxerol), it exerts multimodal pharmacological effects including anti-inflammatory, antioxidant, venotonic, hemostatic, astringent, wound-healing, and vasoprotective actions. These properties target hemorrhoidal pathogenesis by enhancing noradrenaline-induced vasoconstriction, improving venous wall elasticity, reducing capillary permeability, scavenging free radicals, inhibiting NF-κB-mediated cytokine production, and promoting mucosal toughening. Available as 100 mg oral tablets (often twice daily for 14 days), 1% topical cream, or fixed-dose combinations (e.g., with calcium dobesilate or lidocaine), it provides rapid symptom relief in grades 1-4 hemorrhoids, including post-hemorrhoidectomy, with established clinical efficacy and safety in observational studies and trials involving thousands of patients. Patented in India, US, and Europe for anorectal and colonic diseases.[1][5][7][9]

Brand names
SitcomThank OD
Other names
euphorbia prostrataprostrate spurgetrailing red spurge
02

Targets

NF-κB

Beyond the preview

Go deeper on euphorbia prostrata extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on euphorbia prostrata extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call